Epilepsy Seizures Drop 50% in Cannabidiol Study VANCOUVER,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Epilepsy Seizures Drop 50% in Cannabidiol Study

VANCOUVER, British Columbia, Nov. 24, 2014 (GLOBE NEWSWIRE) -- A new study from Orrin Devinsky, MD, of the New York University School of Medicine, suggests that Cannabidiol (CBD) may radically reduce seizures in patients with epilepsy.

Dr. Devinsky administered cannabidiol to 23 patients with treatment-resistant epilepsy. Thirty-nine percent of the patients saw their seizure rates drop by more than 50%. Four patients (17%) had no seizures for the last month of treatment.

Lexaria (CSE:LXX) (OTCQB:LXRP) has acquired 51% of PoViva Corp, an innovative health company developing Cannabidiol (CBD)-infused products. Lexaria may increase its ownership position to 75% at a later date.

"Most CBD's taste awful," stated Lexaria CEO and Chairman Chris Bunka in an exclusive interview with Financial Press . "Marian Washington and Michelle Reillo – the two principals at PoViva – have developed patent-pending technology to bind CBD to a lipid. As well as enabling the body to process the CBDs more efficiently, this technology makes it taste much better."

The first PoViva Tea by Lexaria will be a traditional black tea, which accounts for about 85% of all the tea consumed. Initially Lexaria will sell the CBD lipid-bound tea loosely - and then as the product line gets traction Bunka anticipates introducing flavored teas and tea bags.

In March, 2014 Lexaria entered into the medical marijuana market in Canada where it is legal federally. Its production license application is being reviewed by Health Canada.

"We continue to press for that license," stated Bunka. "But we made an executive and board decision to build immediate value for the company pursuing opportunities in the hemp-based Cannabidiol (CBD) market -  which does not require new licensing, laws or legislation."

The Alternative Health sector is growing fast. A six year survey with 29,370 subjects monitored the adoption of "complementary and alternative medicine care professionals," including "homeopathic, naturopathic, or herbalists."

The study suggests that between 16.9 million and 18.5 million Americans are seeking an alternative health care professional at any given time.

"The US Department of Health has patented CBDs and claimed that they are beneficial in treating Parkinson's, Alzheimer's, Cancer, Cardio-vascular diseases and concussion," stated Bunka. "An overwhelming body of research indicates that Cannabidiol has significant medicinal properties."

Bunka sees Cannabidiol products as much more than a niche health market. There are many patients with Alzheimer's and other diseases who don't want to use marijuana.

Lexaria is planning to market its products to the 150 million daily tea drinkers in the United States. The market for CBDs is much larger than that of marijuana-users.

"We're not changing focus, we're sharpening it," stated Bunka. "We are still in the same sector, but in a 100% legal part of it, which means we can produce foods that contain CBD and create short term cash flows for the company."

Lexaria is in the process of launching a new e-commerce website and setting up a national distribution center, with 1-800 call ordering.

"Our marketing will include traditional media, direct marketing, and we also are building relationships with alternative health media outlets," stated Bunka. "Some of these organizations have expressed interest in affiliate marketing campaigns so we are also exploring that."

Bunka has a conservative approach to alternative medicine, including cannabis. The company has initiated a Responsible Marijuana Policy which states that Lexaria will not sell medical marijuana containing more than 0.3% THC to any medical marijuana patient under the age of 25.

Subsequent to Lexaria's announcement, the College of Family Physicians of Canada created new guidelines that included the recommendation that medical marijuana in most cases would not be appropriate for patients under the age of 25.

Lexaria is currently investigating several popular food and drink sectors where its patent-pending lipid-binding Cannabidiol delivery system might prove effective. Lexaria has acquired a 3-year exclusive right to the patent-pending process to infuse CBD's into all global markets outside of the USA.

The 2015 combined hot beverage markets of coffee and tea together, globally, is expected to be $69 Billion according to a report by Basu Majumder A., Bera B. and Rajan A.

According to the US Department of Health and Human Services Patent number 6,630,507, " Cannabidiol is particularly advantageous to use because it avoids toxicity that is encountered with psychoactive cannabinoids at high doses."

Lexaria continues to pursue the Health Canada MMPR Licensed Producer status by way of its joint venture in Burlington Ontario with Enertopia Corp. Meanwhile Bunka is focussed on producing cash flows from new initiatives; including the CBD-sectors (like epilepsy treatment) derived from already-legal hemp.

According to the Center for Disease Control and Prevention, Epilepsy affects about 2 million people in the United States and accounts for $15.5 billion in direct costs and indirect costs.

Lexaria is currently trading at .09 with a market capitalisation of $3.1 million.

Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the authors only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.

Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.

Lexaria Corp. 950 - 1130 West Pender Street Vancouver BC V6E 4A4 p. 604 602 1675 f. 604 685 1602 e.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 62

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
America's Group Adds Swansea to Its UK Auction Map

Updated Category News Views 128

A Welsh Lane Joins a Larger Road Port Talbot just became a small but telling dot on America's Group's international map. The company has acquired Swansea Motor Vehicle Auction Limited, a long-standing South Wales wholesale and remarketing operation, and plans to run it under the G3 brand. This is not the sort of deal that makes markets levitate. It is the sort that tells...

Continue Reading
Berlin Heals Puts Microcurrent Therapy to a Real Test

Updated Category News Views 56

A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....

Continue Reading
ROHM's GaN PFC Chip Targets the Power-Supply Squeeze

Updated Category News Views 0

Power supplies are where a lot of sleek electronics quietly lose the plot, and ROHM is taking a proper swing at that problem. Its new BM85060FV is a totem-pole power factor correction controller built for gallium nitride, or GaN, high-frequency switching in AC-DC power supplies. The headline is not subtle: ROHM says a 300 to 500 W system using the chip can reach 99%...

Continue Reading
JOYY’s Ad Engine Gives Q3 Growth Some Real Teeth Now

Updated Category News Views 93

Three engines are finally pulling the cart at JOYY, and that is a far more interesting sight than another quarter of livestreaming merely holding together. The company reported third-quarter 2026 revenue of US$624.6 million, up 15.6% from a year earlier and 5.7% sequentially. Those are sturdy numbers, especially for a business that investors have long tended to box in as...

Continue Reading
Replit Bets on Trusted Creators to Sell AI Agents at Work

Updated Category News Views 52

Forty-five creators may sound like a marketing footnote, but Replit is aiming at a real enterprise bottleneck: people do not buy grand AI slogans; they buy proof that a messy internal problem can actually get fixed. Its newly launched Replit & Co. program puts business and technology creators in front of that problem, with product access, demonstrations and direct contact...

Continue Reading
Term or Whole Life: Costs, Coverage, and Trade-Offs

Updated Category News Views 56

A life insurance choice can sit quietly in a drawer for years, then become brutally important at exactly the wrong moment. Laura Wood's November 18, 2026 comparison of term and whole life insurance is useful for that reason: it keeps dragging the conversation back to the unglamorous stuff that actually matters—how long coverage lasts, what it costs, and whether a...

Continue Reading
OCEG Faces China's Demographic Test After 40 Years

Updated Category News Views 83

A school group that once opened 35 kindergartens in a year is admitting the old playbook has run its course. That is the real message behind Oriental Cambridge Education Group's 40th-anniversary talk, not the balloons and ceremonial language. OCEG operates more than 170 institutions across 39 Chinese cities, and its chairman, Yu Yue, says the next chapter will be judged...

Continue Reading
U.S. Patriot's Veteran Hiring Earns a Real National Nod

Updated Category News Views 58

A workforce award can be cheap wallpaper, but this one has some heft. U.S. Patriot, the veteran-founded and veteran-led military goods retailer owned by GALLS, landed on Military Times’ 2026 Best for Vets: Employers list, placing third in retail and first in Kentucky. The recognition covers 250 organizations, and this is U.S. Patriot’s fourth consecutive appearance....

Continue Reading
Italian Wine Faces U.S. Slump and New Market Openings

Updated Category News Views 133

American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....

Continue Reading

Top 5 Most Recently Viewed Articles

Proaction Secures $4.2M to Challenge Legacy Fleet Firms

Updated Category News Views 129

Fleet Management: A Market Ripe for Disruption You ever cruised past an old clunker of a business model and thought, "Now there's a setup ripe for a rethink"? That's exactly what Proaction's up to with their recent $4.2 million cash injection. For anyone keeping tabs on the legacy fleet management scene, it’s like watching someone take a claw hammer to a creaky old...

Continue Reading
Mission Bio Unveils Groundbreaking Solution for Genome Analysis

Updated Category News Views 161

Mission Bio dropped the bomb back in 2024 with its Tapestri Genome Integrity CNV Solution, a serious piece of kit aimed at transforming how researchers tackle genomic integrity. This ain't just another offering; it’s the first single-cell high-throughput solution that measures genome-wide copy number variations (CNVs). Think of it as a lifeline for those deep in...

Continue Reading
Varonis Shines as a Leader in Data Security Platforms

Updated Category News Views 286

Varonis Receives Prestigious Recognition in Data Security Varonis Systems, Inc. (Nasdaq: VRNS) is excited to receive acknowledgment as a Leader within the data security landscape, as highlighted by a prominent research firm in their latest report. This recognition emphasizes Varonis’ commitment to securing data effectively while continuously evolving their platform to...

Continue Reading
CocoFest 2025: Embracing Community and Wellness Together

Updated Category News Views 497

CocoFest 2025: A Celebration of Community and Wellness CocoFest is returning for its third rendition, bringing together people for a day dedicated to celebrating love and wellness. This exciting event will take place on a Saturday at the Boca Raton Innovation Campus, showcasing how love can enhance our lives in various ways. What to Expect at CocoFest 2025 The festival...

Continue Reading
Innovative Speech Therapy Game Enhances Learning for Kids

Updated Category News Views 169

Innovative Speech Therapy Game Revolutionizes Learning In a vibrant city, an inventive mind has crafted a special game designed to make speech therapy more engaging for children. This game, known as LINGUA TOKENS, aims to bring excitement into learning fundamental speech skills. With a focus on fun, children aged 4 to 9 can enhance their articulation through play-based...

Continue Reading